These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18089295)

  • 1. What determines drug solubility in lipid vehicles: is it predictable?
    Rane SS; Anderson BD
    Adv Drug Deliv Rev; 2008 Mar; 60(6):638-56. PubMed ID: 18089295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical properties of water and its effect on drug delivery. A commentary.
    Loftsson T; Brewster ME
    Int J Pharm; 2008 Apr; 354(1-2):248-54. PubMed ID: 17920796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters.
    Jouyban A; Soltanpour Sh; Soltani S; Chan HK; Acree WE
    J Pharm Pharm Sci; 2007; 10(3):263-77. PubMed ID: 17727790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of membrane-solvent-solute interactions on solute permeation in model membranes.
    Dias M; Hadgraft J; Lane ME
    Int J Pharm; 2007 May; 336(1):108-14. PubMed ID: 17204382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting aqueous solubility from structure.
    Delaney JS
    Drug Discov Today; 2005 Feb; 10(4):289-95. PubMed ID: 15708748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
    Subramanian N; Ghosal SK
    Indian J Exp Biol; 2004 Nov; 42(11):1056-65. PubMed ID: 15587110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of lipid emulsion for ocular delivery of lipophilic drugs.
    Tamilvanan S; Benita S
    Eur J Pharm Biopharm; 2004 Sep; 58(2):357-68. PubMed ID: 15296961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.